Amgen Inc.

Equities

AMGN

US0311621009

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-12 pm EDT			5-day change	1st Jan Change
367.79 ^USD	-2.61%		+0.05%	+12.37%

Mar. 12	GRAIL, Inc. Announces Board Changes	CI
Mar. 12	GRAIL, Inc. Announces Chief Executive Officer Changes, Effective June 1, 2026	CI

Transcript : Amgen Inc. Presents at Citi?s 2026 Virtual Oncology Leadership Summit, Feb-18-2026 03

Published on 02/18/2026 at 05:31 pm EST

S&P Capital IQ

Presenter Speech
Geoffrey Meacham (Analysts)

All right. Welcome to the afternoon sessions of Citi's Virtual Oncology Leadership Summit. My name is Geoff Meacham. I'm the Senior Biopharma Analyst here

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Amgen Inc.

Mar. 12	GRAIL, Inc. Announces Board Changes	CI
Mar. 12	GRAIL, Inc. Announces Chief Executive Officer Changes, Effective June 1, 2026	CI
Mar. 12	Grail CEO Bob Ragusa to retire, Josh Ofman named successor	RE
Mar. 11	Amgen Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-11-2026 09:20 AM
Mar. 10	Equinix, Inc. Appoints Olivier Leonetti as Chief Financial Officer, Effective March 16, 2026	CI
Mar. 09	Global drugmakers rush to boost US presence as tariff threat looms	RE
Mar. 09	LB Pharmaceuticals Inc Appoints Robert Lenz, M.D., Ph.D. to Board of Directors	CI
Mar. 05	Arcutis Biotherapeutics, Inc. Announces Promotion of Mas Matsuda to Executive Vice President, Chief Legal Officer, and Corporate Secretary	CI
Mar. 05	Illumina, Inc. and Nashville Biosciences, LLC Announce New Proteomics Data Offering and Expansion of Alliance for Genomic Discovery Dataset	CI
Mar. 04	Amgen Keeps Quarterly Dividend at $2.52 a Share, Payable June 5 to Holders of Record May 15	MT
Mar. 04	Amgen announces 2026 second quarter dividend	RE
Mar. 04	Amgen Announces 2026 Second Quarter Dividend, Payable on June 5, 2026	CI
Mar. 04	Tivic Health Systems, Inc. Announces CEO Changes	CI
Mar. 04	Tivic Health Systems, Inc. Announces Board Changes	CI
Mar. 04	NervGen Pharma Corp. Announces Executive Changes	CI